Molecular mechanisms of multidrug resistance in clinically relevant enteropathogenic bacteria (Review)

Julia Alexsandra González-Villarreal1, Katia Jamileth González-Lozano2, Elva Teresa Aréchiga-Carvajal2

  • 1Faculty of Biological Sciences, Autonomous University of Coahuila, Torreón, Coahuila 27275, Mexico.

Insights

Multidrug resistant (MDR) bacteria pose a significant clinical challenge. This review explores their genomic resistance mechanisms and treatment strategies for developing new antimicrobials.

Area of Science:

  • Microbiology
  • Genomics
  • Pharmacology

Background:

  • Multidrug resistant (MDR) enteropathogenic bacteria present a growing clinical challenge.
  • Their acquired tolerance to antibiotics leads to severe illnesses and significant healthcare costs.
  • Understanding MDR mechanisms is crucial for effective treatment and control.

Purpose of the Study:

  • To review the genomic mechanisms of antibiotic resistance in bacteria, including naturally acquired resistance.
  • To discuss current pharmacological and alternative treatments for MDR bacterial infections.
  • To provide information for developing novel antimicrobials and adjuvant therapies.

Main Methods:

  • Genomic analysis of antibiotic resistance mechanisms.
  • Literature review of pharmacological and alternative treatments.
  • Synthesis of information for antimicrobial development.

Main Results:

  • Detailed description of genomic basis for MDR in enteropathogenic bacteria.
  • Overview of existing treatment options for MDR infections.
  • Identification of targets for novel antimicrobial development.

Conclusions:

  • Genomic insights are vital for combating MDR bacteria.
  • A combination of established and novel treatments is necessary.
  • Further research into antimicrobial and adjuvant molecule development is essential.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
82
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
490
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
673
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
732
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
192